Specialty pharmaceuticals firm Accentia (Tampa, FL) has acquired an 81% controlling stake in bidpharma developer and contract manufacturer Biovest (Minneapolis) for $20 million in cash and notes. Biovest specializes in contract manufacturing of biologics, including protein therapeutics, monoclonal antibodies, cytokines, and cell amplification technologies.' Biovest's patented production technology, a hollow-fiber bioreactor, isa cost-effective route for …
No comments:
Post a Comment